Every 10-Q that Atlas Lithium Corporation (ATLX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ATLX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATLX filings page.
Atlas Lithium Corporation reported another pre-production quarter as it advances its Neves hard‑rock lithium project in Brazil toward first output. For the three months ended June 30, 2026, it generated no revenue and recorded a net loss of $11.5 million, wider than a year earlier, driven mainly by higher payroll and third‑party costs tied to project implementation and permitting, plus increased stock‑based compensation.
For the first half of 2026, net loss reached $28.0 million. Operating cash outflow rose to $18.2 million, but was funded by $20.4 million of financing inflows, including $11.3 million from ATM share sales and $9.6 million from the public offering of consolidated subsidiary Atlas Critical Minerals. Cash and cash equivalents were $36.1 million and working capital about $22.1 million as of June 30, 2026.
The company continued to de‑risk Neves, securing an expansion permit, selecting key EPC and assembly contractors, and highlighting that its fully paid processing plant is ready for installation. All operations and long‑lived assets remain in Brazil, with functional currency for Brazilian subsidiaries changed to the U.S. dollar. Atlas also uses non‑deliverable forwards as cash‑flow hedges for Brazilian real expenses.
Atlas Lithium Corporation reported a wider net loss as it continues to invest heavily in developing its Brazilian lithium assets. For the three months ended March 31, 2026, net loss was $16.5 million versus $10.2 million a year earlier, driven mainly by higher general and administrative and stock-based compensation expenses.
Net revenue rose to $74,386 from $25,175, while cash and cash equivalents were $34.4 million and total assets $87.4 million. The company remains focused on advancing its Neves lithium project in Minas Gerais, supported by a DMS processing plant and an at-the-market equity program.
Atlas Lithium consolidated its 20.26% stake in Atlas Critical Minerals, which listed on Nasdaq and raised capital, and highlighted that Neves was named in a Japan-U.S. critical minerals cooperation fact sheet. Management believes existing liquidity will fund operations for at least twelve months, though continued external financing may be needed for long-term growth.
Atlas Lithium Corporation (ATLX) filed its Q3 2025 report, highlighting continued project development and financing progress. The company reported a net loss attributable to stockholders of $6,953,276 for the quarter and $21,529,466 for the nine months. Basic and diluted loss per share was $0.35 for the quarter and $1.18 year-to-date.
Cash and cash equivalents were $20,977,191, up from $15,537,476 at year-end, with total assets of $72,169,028. Operating cash outflows were $15,365,255 for the nine months, offset by $28,687,888 of financing inflows, primarily from at-the-market (ATM) equity sales. During Q3 2025, the company sold 2,916,366 common shares under its ATM programs, generating aggregate net proceeds of approximately $15.1 million. Property and equipment reached $46,949,039 as the Neves Lithium Project advanced: the project received a mining concession on May 27, 2025, completed a Definitive Feasibility Study on August 4, 2025, and has a fully paid dense media separation plant in Brazil, with the DFS citing an expected lithium recovery rate of 61.7% and estimated capital expenditures of $57.6 million. Convertible debt stood at $10,131,347. As of November 10, 2025, there were 23,570,445 common shares outstanding.